healthcare
Matrix India invests in Mewar Orthopaedic
Matrix Partners India has taken a minority stake in specialty healthcare provider Mewar Orthopaedic Hospitals for an undisclosed amount as part of a Series A round of investment.
VCs channel $25m into China’s Innovent Biologics
Innovent Biologics, a China-based manufacturer of monoclonal antibodies, has raised $25 million in Series B financing from Lilly Asia Ventures, the VC arm of global pharmaceutical company Eli Lilly, and existing investors Fidelity Biosciences and Fidelity...
Sequoia India invests $6.1m in pathology chain
Sequioa Capital has invested INR400million ($7.5 million) in Indian pathology services provider Suburban Diagnositic for a 30% stake.
Fidelity commits $74m to India’s Trivitron Healthcare
Fidelity Growth Partners India has invested INR4 billion ($74.4 million) in medical technology firm Trivitron Healthcare. The funding will be used to make lateral acquisitions in Europe and the US as well as to improve the Chennai-headquartered company’s...
Shanghai VC firm launches JV with MicuRx Pharma
Shanghai Zhangjiang Biomedical Industry Venture Capital has formed a joint venture with MicuRx Pharma, a Sino-US bio-pharmaceutical company, to support the development and commercialization of antibiotic MRX-I for the Chinese market.
J-Star sees 3x return on consolidation play
Fierce competition among the middle-men in Japan’s pharmaceutical industry has created a healthy environment for private equity firms looking to consolidate a fragmented sector. Last week J-Star exited Apo Plus Station (APS) after a two-year holding...
IFC to anchor Fosun Pharma’s Hong Kong IPO
International Finance Corporation (IFC), the investment arm of the World Bank, is expected to anchor Shanghai Fosun Pharmaceutical’s Hong Kong IPO alongside Prudential Financial. The total cornerstone commitment is $75 million out of a targeted $600...
Japan’s J-Star sees 3x return on Apo Plus Station
Mid-market Japanese GP J-Star has sold its majority stake in the pharma-focused contract sales company Apo Plus Station (APS) to Qol, a Tokyo-based pharmaceutical firm.
Hong Kong PE firm backs heart failure treatment
Hong Kong-based Themes Investment Partners has led a $20 million equity financing round in LoneStar Heart, a California-based biomedical company developing new therapies for patients with heart failure.
Actis supports Sri Lanka hospital consolidation
For Asiri Hospital Holdings (AHH) in Sri Lanka, read India’s Sterling Hospitals in India. Actis, which has acquired a $32 million equity stake in the Sri Lankan healthcare operator, found itself looking at a similar market dynamic when it first invested...
Actis invests in Sri Lankan hospital chain
Emerging markets-focused private equity firm Actis has invested $32 million for approximately 30% of Asiri Hospital Holdings (AHH), Sri Lanka’s largest private hospital group. The company operates three facilities in Colombo and two in Matara, with...
NVP invests $22m in Indian medical diagnostics firm
Norwest Venture Partners (NVP) has bought a 10% stake in India’s Thyrocare Technologies from the medical diagnostics services provider’s promoters for INR1.2 billion ($22 million).
Wellington Partners leads $3.4m Series A for AyoxxA Biosystems
Wellington Partners Venture Capital has led a EUR2.6 million ($3.4 million) Series A round of financing in AyoxxA Biosystems, a biotech firm based in Singapore and Germany. The capital will provide AyoxxA with the resources to scale-up production of bead-based...
IndoUS Ventures leads Vyome Biosciences Series A round Partners
Vyome Biosciences, a Delhi-based biopharmaceutical company that focuses on dermatology, has raised $3.3 million in Series A financing. The round was led by IndoUS Venture Partners, with Aarin Capital and existing investor Navam Capital also participating.
PE-backed Max India sells polypropylene film unit for $97m
Max India, which is backed by Goldman Sachs, International Financial Corporation (IFC) and Temasek Holdings, has sold its biaxially oriented polypropylene (BOPP) film division to Germany's Treofan for INR5.4 billion ($97 million). The divestment allows...
CITIC PE backs $331m take-private bid for China’s 3SBio
CITIC Private Equity is supporting a $331 million management buyout offer for NASDAQ-listed Chinese pharmaceuticals company 3SBio. It is the latest in a string of attempted take-private deals for US-traded Chinese firms that for a variety of reasons are...
RRJ Capital invests $50m in Chinese biotech firm - source
RRJ Capital is said to have injected $50 million in Chinese biotech company Triplex Biosciences, taking an 11-19% stake in the company.
NVP backs Indian healthcare clinics with $4.5m
Norwest Venture Partners (NVP) has invested INR250 million ($4.5 million) in NationWide Primary Healthcare Services, an Indian retail chain of primary care clinics.
Olympus-backed DM Healthcare outlines India spending plans
Olympus-backed DM Healthcare, a Dubai-based healthcare services provider which gets a majority of its business in the Middle East, will invest INR15 billion ($270 million) in India. The company hopes this will help boost overall revenues by 40% to INR23...
IFC invests $47m in China’s Fosun Pharma
International Finance Corporation (IFC), the private investment arm of the World Bank, has agreed to provide RMB300 million ($47 million) in funding to Fosun Pharma, one of China’s leading drug companies. The investment will help Fosun scale up the...
India Value Advisors to invest $179m in Manipal Hospitals
India Value Advisors (IVFA) will commit about INR10 billion ($179 million) to Manipal Hospitals over a three-year period, enabling the healthcare provider to more than double its hospital bed capacity. Part of this increase will come through acquisitions.
Buyout firms progress in Indonesia healthcare auction - report
The Blackstone Group, Bain Capital, KKR and Abraaj Capital are said to have made it through to the second round of the auction process for a 20% stake in Siloam, Indonesia’s biggest private hospital firm. The deal is expected to be worth up to $300...
Archer Growth prepares for Cura Day exit – report
Archer Capital Growth is reportedly preparing to exit Cura Day Hospitals Group. The Australian GP helped found the company in 2008, having teamed up with a group of doctors and medical specialists who manage and work at its nationwide network of day hospitals.
Carlyle sees rare scale opportunity in Meinian Onehealth
The Carlyle Group was drawn to China’s Meinian Onehealth because it represented one of few true nationwide healthcare services providers in a fragmented market.